Purpose of the study. Evaluate the prognostic value of an independent and medical fence of the vaginal discharge for the HPV test

Cover Page

Cite item

Full Text

Abstract

The aim of the study is to assess the prognostic value of self-and medical sampling of vaginal discharge for HPV test. Materials and methods. The study included 200 women aged 18-45 years (mean age 32.7±6.9 years) who underwent traditional cytological testing and testing for HPV-stimulated stimulation. The vaginal secretion for the identification of HPV DNA by polymerase chain reaction (PCR) was performed by a woman alone using a Qvintip device and a doctor from the cervical canal. The predictive value of these techniques was evaluated according to generally accepted formulas. Results. 42% of those surveyed had HPV-stimulated stimulation. The most common types were HPV-16 (17.7%), HPV-56 (16.3%), HPV-39 (13.6%). 51.2% of HPV-positive women had a combination of several types of HPV-stimulated stimulation. The effectiveness of the examination with the Qvintip device was higher than when the doctor took the material: 38% vs 27.5% (OR=1.6, 95% CI 0.48-2.45, χ2=5.0, pχ2=0.025). The Qvintip device detected a 5-fold increase in HPV-SRV: 34.5% vs 9.5% (OR=5.0, 95% CI 1.61-6.71, χ2=15.3, pχ2=0.0001). An abnormal cytological picture was found only in HPV-positive women in 17.9% (χ2=19.9, pχ2=0.0005), of which LSIL were detected in 15.5% of cases, HSIL-2.4%. A comparative assessment of prognostic value revealed a higher sensitivity of the self-sampling method (100%) compared with the medical fence of the material (66.7%). High specificity of both methods of preparation of samples for HPV-test was revealed: 65% for independent and 72% for medical. The conclusion. The Qvintip device for self-sampling vaginal discharge for the HPV test has a high predictive value and can be recommended as an alternative method for screening cervical cancer.

About the authors

T E Belokrinitskaya

Chita State Medical Academy of the Ministry of Health of the Russian Federation

Email: tanbell24@mail.ru
д-р мед. наук, проф. зав. каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС 672000, Russian Federation, Chita, ul. Gor'kogo, d. 39a

O V Turanova

Chita State Medical Academy of the Ministry of Health of the Russian Federation

Email: oksana-kryzhnova@mail.ru
клин. ординатор каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС 672000, Russian Federation, Chita, ul. Gor'kogo, d. 39a

N I Frolova

Chita State Medical Academy of the Ministry of Health of the Russian Federation

Email: taasyaa@mail.ru
канд. мед. наук, ассистент каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС 672000, Russian Federation, Chita, ul. Gor'kogo, d. 39a

References

  1. Bruni L, Barrionuevo-Rosas L, Albero G et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2016.
  2. Comprehensive Cervical Cancer Control. A guide to essential practice Second edition. World Health Organization, 2014.
  3. Del Mistro A, Frayle H, Ferro A et al. Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round. Prev Med Rep 2016; 5: 166-68. doi: 10.1016/j.pmedr.2016.12.017. eCollection 2017
  4. Bosch F.X, Broker T.R, Forman D. et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31 (Suppl. 7): H1-31.
  5. Сухих Г.Т., Прилепская В.Н. Профилактика рака шейки матки: руководство для врачей. Изд. 3-е. М.: МЕДпресс-информ, 2012.
  6. Lorincz A, Castanon A, Wey Wey Lim A, Sasieni P. New Strategies for HPV-based Cervical Screening. Wom Health (Lond Engl) 2013; 9 (5): 10. doi: 10.2217/whe.13.48 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880859/
  7. Deleré Y, Schuster M, Vartazarowa E et al. Cervicovaginal Self-Sampling Is a Reliable Method for Determination of Prevalence of Human Papillomavirus Genotypes in Women Aged 20 to 30 Years. J Clin Microbiol 2011; 49 (10): 3519-22.
  8. СDC. Cervical cancer is preventable 2014. http://www.cdc.gov/vitalsigns/cervical-cancer
  9. Роговская С.И. Практическая кольпоскопия. Изд. 4-е. М.: ГЭОТАР-Медиа, 2016
  10. Белокриницкая Т.Е., Фролова Н.И., Туранова О.В. и др. Самостоятельный vs врачебный забор материала для ВПЧ-теста: результативность и приемлемость у пациенток разных возрастных групп. Доктор Ру. 2017; 7 (136): 8-14.
  11. Shaniqua L, Jeanne M.F. Update on prevention and screening of cervical cancer. World J Clin Oncol 2014; 5 (4): 744-52. doi: 10.5306/wjco.v5.i4.744
  12. Кисин В.И. Инфекции, передаваемые половым путем. Протоколы ведения больных. М.: Ньюдиамед, 2014.
  13. WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women. World Health Organization, 2013.
  14. Wright T.C, Stoler M.H, Behrens C.M et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015;
  15. (2): 189-97.
  16. Katki H.A, Kinney W.K, Fetterman B et al. Cervical Cancer Risk for 330,000 Women Undergoing Concurrent HPV Testing and Cervical Cytology in Routine Clinical Practice at a Large Managed Care Organization. Lancet Oncol 2011; 12 (7): 663-72.
  17. Chen K, Ouyang Y, Hillemanns P, Jentschke M. Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population. J Obstet Gynaecol Res 2016; 42 (12): 1839-45. doi: 10.1111/jog.13132. Epub 2016 Sep 20.
  18. Jentschke M, Chen K, Arbyn M et al. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol 2016; 82: 46-50. doi: 10.1016/j.jcv.2016.06.016. Epub 2016 Jun 28.
  19. Bhatla N, Dar L, Patro A.R et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009; 33 (6): 446-50.
  20. Szarewski A, Cadman L, Mallett S et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007; 14 (1): 34-42.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).